(MedPage Today) -- Faulty INR measurements didn't affect pivotal trial results, agency says
via CardioBrief: FDA Reaffirms Safety and Efficacy of Rivaroxaban
by
Showing posts with label CardioBrief: FDA Reaffirms Safety and Efficacy of Rivaroxaban. Show all posts
Showing posts with label CardioBrief: FDA Reaffirms Safety and Efficacy of Rivaroxaban. Show all posts
Tuesday, October 11, 2016
Subscribe to:
Posts (Atom)